Bladder botulinum toxin A injection can benefit patients with radiation and chemical cystitis

BJU International

Volumn 102, Issue 6, 2008, Pages 704-706

  Chuang, Yao Chi ^a,b   Kim, Dae Kyung ^c   Chiang, Po Hui ^b   Chancellor, Michael B ^d  

^a Chang Gung University College of Medicine ^*  (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c Eulji University School of Medicine   (South Korea)

^d WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Botulinum toxin; Chemical cystitis; Radiation cystitis

Indexed keywords

BCG VACCINE; BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; BLADDER CAPACITY; CHEMICAL CYSTITIS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTITIS; DRUG RETENTION; EOSINOPHIL; FEMALE; HUMAN; MALE; PAIN; PRIORITY JOURNAL; RADIATION; RADIATION SICKNESS; SCORING SYSTEM; URINARY FREQUENCY; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRAVESICAL; AGED; BCG VACCINE; BOTULINUM TOXIN TYPE A; CYSTITIS; HUMANS; PAIN; PAIN MEASUREMENT; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER;

EID: 50049122634     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07740.x     Document Type: Article

References (19)

1. Farquharson DI, Shingleton HM, Sanford SP, Soong SJ, Varner RE Jr., Hester S. The short-term effect of pelvic irradiation for gynecologic malignancies on bladder function. Obstet Gynecol 1987 70 : 81 4
2. Wines MP, Lynch WD. A new minimally invasive technique for treating radiation cystitis: the argon-beam coagulator. BJU Int 2006 98 : 610 2
3. Shelley MD, Kynaston H, Court J et al. A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer. BJU Int 2001 88 : 209 16
4. Palou J, Rodríguez-Villamil L, Andreu-Crespo A, Salvador-Bayarri J, Vicente-Rodríguez J. Intravesical treatment of severe bacillus Calmette-Guerin cystitis. Int Urol Nephrol 2001 33 : 485 9
5. Smith CP, Chancellor MB. Emerging role of botulinum toxin in the treatment of voiding dysfunction. J Urol 2004 171 : 2128 37
6. Chapple C, Patel A. Botulinum toxin - new mechanisms, new therapeutic directions? Eur Urol 2006 49 : 606 8
7. Schurch B, Hauri D, Rodic B, Curt A, Meyer M, Rossier AB. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 1996 155 : 1023 9
8. Phelan MW, Franks M, Somogyi GT et al. Botulinum toxin urethral sphincter injection to restore bladder emptying in men and women with voiding dysfunction. J Urol 2001 165 : 1107 10
9. Dmochowski R, Sand PK. Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int 2007 99 : 247 62
10. Vemulakonda VM, Somogyi GT, Kiss S, Salas NA, Boone TB, Smith CP. Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation. J Urol 2005 173 : 621 4
11. Chuang YC, Yoshimura N, Huang CC, Chiang PH, Chancellor MB. Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 2004 172 : 1529 32
12. Lucioni A, Bales GT, Lotan TL, McGehee DS, Cook SP, Rapp DE. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int 2008 101 : 366 70
13. Chuang YC, Yoshimura N, Wu M et al. Intraprostatic capsaicin injection as a novel model for nonbacterial prostatitis and effects of botulinum toxin A. Eur Urol 2007 51 : 1119 27
14. Sahai A, Khan MS, Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 2007 177 : 2231 6
15. Smith CP, Radziszewski P, Borkowski A, Somogyi GT, Boone TB, Chancellor MB. Botulinum toxin A has antinociceptive effects in treating interstitial cystitis. Urology 2004 64 : 871 5
16. Liu HT, Kuo HC. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology 2007 70 : 463 8
17. Jaal J, Dorr W. Radiation induced inflammatory changes in the mouse bladder: the role of cyclooxygenase-2. J Urol 2006 175 : 1529 33
18. Schurch B, de Seze M, Denys P et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005 174 : 196 200
19. Naumann M, Jankovic J. Safety of botulinum toxin type A: a systematic review and meta-analysis. Curr Med Res Opin 2004 20 : 981 90